DePuy’s Faulty Hip Replacement Shadow Lingers As India Issues Recall
This article was originally published in PharmAsia News
Executive Summary
The device manufacturer is under increasing regulatory pressure on the measures it took to inform patients or reimburse for tests and revision surgeries.